Evolution. Expansion. Bridging. This is what we know. Our evolution into a leading full service pharmacology unit continues as we use our history in dermatology to cultivate and sharpen our skill set. Transferring this acquired knowledge and expertise, we developed and continuously refine our comprehensive TKL Approach. Expansion is inevitable when using our unique approach to tackle new areas of therapeutic...
TKL is excited to announce the opening of our 5th location - TKL Research Jersey City. Our ongoing commitment to offering our sponsors one of the most diverse patient populations in the U.S., as well as a need for more clinical space led us to Jersey City, NJ - a densely populated, urban environment. Our site is located in the heart...
The New Design Standard for Clinical Trials. Based on a 2013 study with Novartis for BioMedical Research, TKL Research developed a study that was approved and accepted by the FDA as a comprehensive design to test the photosensitization potential of the investigational product...
Things have been busy at TKL Research. Our clinical studies team recently wrapped up a study with Sun Pharmaceuticals evaluating the taste, grittiness and overall acceptability of Metformin HCl extended release powder in various flavors vs the current immediate release tablets and oral suspension. The problems surrounding the current formulation of the immediate release tablets and oral suspension were the inconvenient...
TKL Research is excited to announce the launch of our new mobile application for subject recruitment and retention....
